How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

28,354 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

27741. Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments

blanching response to Reference Drug Weight within +/- 20% from normal for height and weight for body frame Good health as determined by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids Presence of any skin condition or coloration that would interfere (...) Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2008 Clinical Trials

27742. Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching Presence of medical condition requiring regular treatment with prescription drugs Drug or alcohol addiction requiring treatment in the past 12 months prior to dosing Use of any (...) Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2008 Clinical Trials

27743. Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments

by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching Presence of medical condition requiring regular treatment with prescription drugs Drug or alcohol addiction requiring treatment in the past 12 months prior to dosing Use of any (...) Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2008 Clinical Trials

27744. Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams

and clinical assessment, as judged by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching Presence of medical condition requiring regular treatment with prescription drugs Drug or alcohol addiction requiring treatment in the past (...) Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove

2008 Clinical Trials

27745. Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

to Reference Drug Body Mass Index (BMI) of 30 or less Good health as determined by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids Presence on any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin (...) Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2008 Clinical Trials

27746. Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema

2010 Estimated Study Completion Date : January 2010 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: brimonidine 50 patients receiving Brimonidine Tartrate drops in the operated eye: 1 drop X2 a day for 1 month. they will also be administered the usual medications after cataract surgery (corticosteroids and antibiotics drops) Drug: Brimonidine Tartrate 0.2% Brimonidine Tartrate 0.2% drops (...) Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effect of Topical

2008 Clinical Trials

27747. Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams

years of age Demonstrated blanching response to Reference Drug (augmented betamethasone dipropionate) Cream 0.05% Weight within + or - 20% from normal for height and weight for body frame Good health as determined by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids (...) Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2008 Clinical Trials

27748. Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee

Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00800098 Recruitment Status : Completed First Posted : December 1, 2008

2008 Clinical Trials

27749. Study of a New Dressing for Use With Topical Medications

Guttate, pustular, erythrodermic, or other non-plaque forms of psoriasis Spontaneously worsening or improving psoriasis within 30 days of enrollment Any evidence of atrophy in the areas selected for treatment with topical corticosteroid History of treating potential target lesions differently from one another Topical or intralesional therapies (other than emollients) or UVB phototherapy on potential target lesions within two weeks of starting study treatment Systemic therapy, PUVA phototherapy (...) Study of a New Dressing for Use With Topical Medications Study of a New Dressing for Use With Topical Medications - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study of a New Dressing for Use With Topical

2005 Clinical Trials

27750. Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

, tricyclic antidepressants, probenecid, topical or systemic antiviral drugs or immunomodulatory agents for viral infection herpes zoster ophthalmicus female patients who are pregnant and/or nursing or planning a pregnancy congenital, acquired or corticosteroid-induced immunodeficiency, including malignancy renal insufficiency or creatinine level >2mg/dL clinical significant liver enzyme abnormalities and any other laboratory abnormalities determined by the screening lab history of intolerance (...) Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles) Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results

2008 Clinical Trials

27751. An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

the 6 months prior to the screening period Treatment with systemic immunomodulators or immunosuppressants within the 6 months prior to the screening period Use of topical immunomodulators within 2 cm of the target SCCIS lesion within the 4 weeks prior to the screening period Treatment with the following topical agents within the 4 weeks prior to the screening visit; levulinic acid, 5-fluorouracil, corticosteroids, retinoids, diclofenac, hyaluronic acid, imiquimod Undergone a facial resurfacing (...) An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2008 Clinical Trials

27752. Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers

Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) the maximum number of saved studies (100). Please remove one or more studies before adding more. Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00656825 Recruitment Status

2008 Clinical Trials

27753. Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit

of prescription topical therapy for atopic dermatitis (e.g., corticosteroids or retinoids) within the past 2 weeks. Use of any investigational therapy within the past 4 weeks. Pregnant females, females who are breast feeding, or females of childbearing potential who are not practicing an acceptable method of birth control (abstinence, birth control pill/patch, barrier with spermicidal jelly, IUD, etc.), as determined by the investigator. Acceptable contraception must be used during the entire study (...) Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2008 Clinical Trials

27754. Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

of guttate, pustular, erythrodermic, or other non-plaque forms of psoriasis. Use of emollients or moisturizers on areas to be treated within 24 hours prior to Visits 1 or 2. Use of topical antipsoriatic therapy (including topical retinoids, corticosteroids, or vitamin D analogs) on the areas to be treated within 2 weeks prior to Visit 2. Received systemic immunomodulatory therapy to treat psoriasis (eg, methotrexate, cyclosporine, alefacept, etanercept, infliximab, efalizumab, adalimumab) within 12 weeks (...) Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2008 Clinical Trials

27755. Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

, cytokines) Chemotherapeutic or cytotoxic agents; Investigational agent Treatment within the past 30 days with any of the following: Surgical excision Photodynamic therapy Curettage Topical corticosteroids Laser Dermabrasion Chemical peel Imiquimod 5% cream Topical retinoids 5-fluorouracil Masoprocol Pimecrolimus or tacrolimus Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using (...) Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2008 Clinical Trials

27756. Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers

Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00764361 Recruitment Status : Completed First Posted : October 2, 2008 Results First Posted : April 5, 2012 Last Update Posted : April 7, 2017 Sponsor: NanoSHIFT

2008 Clinical Trials

27757. Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses

of study start Subjects with use of topical medications such as corticosteroids, alpha-hydroxyacids or retinoids 2 weeks before study entry Subjects who received previous treatment of target AKs within 4 weeks Subjects who are unable to understand the protocol or give informed consent Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor (...) Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies

2008 Clinical Trials

27758. A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars

A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved (...) Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our

2008 Clinical Trials

27759. IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids

ocular hypertension after the drug is injected into the eye. Similar to IVTA, topically administered corticosteroids eye drops result in ocular hypertension in approximately 33% of the population. It is unknown whether identifying patients who develop ocular hypertension from topical corticosteroids could be used to identify patients who are at risk for injectable IVTA. Therefore, the purpose of this study is to evaluate the efficacy of topical prednisolone 1% four times daily for one month (...) IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2008 Clinical Trials

27760. A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies

): Genentech, Inc. Study Details Study Description Go to Brief Summary: This study is an open label, randomized, multicenter study designed to compare the efficacy of 12 weeks of subcutaneously administered efalizumab (monotherapy) with that of combination therapy (Efalizumab and a topical corticosteroid ointment) in subjects with moderate to severe plaque psoriasis who are candidates for systemic therapy. The study will also evaluate the safety and tolerability of 30 months of continuous efalizumab (...) ., etanercept, LFA3TIP) History of severe allergic reactions to or intolerance of topical corticosteroid therapies Previous treatment with efalizumab History of treatment with lymphocyte-depleting monoclonal antibodies or immunoadhesion molecules (e.g., anti-CD4, CTLA4-Ig, LFA3TIP) WBC count <4000/uL or >14,000/uL Hepatic enzymes >=3 times the upper limit of normal Creatinine >=2 times the upper limit of normal Any medical condition that, in the judgment of the investigator, would jeopardize the subject's

2004 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>